| scholarly article | Q13442814 |
| P2093 | author name string | C. T. Dollery | |
| M. Widman | |||
| M. Nordqvist | |||
| R. H. Briant | |||
| P2860 | cites work | Distribution of Δ9-tetrahydrocannabinol in the mouse | Q35174467 |
| Distribution and metabolism in vivo of 14C-tetrahydrocannabinol in the rat. | Q48549650 | ||
| Whole-body autoradiography of the pregnant mouse after administration of 14C-Δ9-THC | Q48757660 | ||
| Distribution of tritiated-1 delta 9tetrahydrocannabinol in rat tissues after inhalation | Q48910139 | ||
| On the metabolism of tritium-labelled Δ1-tetrahydrocannabinol in the rabbit | Q48924054 | ||
| [Identification of potential cannalis containing substance metabolites: nuclear resonance and mass spectroscopic studies on side chain hydroxylation of cannabinoids] | Q54248464 | ||
| Biliary excretion of delta1-tetrahydrocannabinol and its metabolites in the rat. | Q54759775 | ||
| Metabolism of delta 9 -tetrahydrocannabinol by lung and liver homogenates of rats treated with methylcholanthrene | Q69955347 | ||
| Two cannabidiol metabolites formed by rat liver | Q70038415 | ||
| The metabolism of sympathomimetic bronchodilator drugs by the isolated perfused dog lung | Q70045133 | ||
| (−)-Δ8-tetrahydrocannabinol: Two novel in vitro metabolites | Q70622527 | ||
| Mass spectroscopy and its application to structural and stereochemical problems. 68. Mass spectroscopic studies of constituents of hashish | Q72692582 | ||
| P433 | issue | 11 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | pharmacology | Q128406 |
| tetrahydrocannabinol | Q190067 | ||
| cannabinoids | Q422936 | ||
| pharmaceutical science | Q7180763 | ||
| P304 | page(s) | 842-848 | |
| P577 | publication date | 1975-11-01 | |
| P1433 | published in | Journal of Pharmacy and Pharmacology | Q10532762 |
| P1476 | title | Metabolism of delta1-tetrahydrocannabinol by the isolated perfused dog lung. Comparison with in vitro liver metabolism | |
| Metabolism of Δ1-tetrahydrocannabinol by the isolated perfused dog lung. Comparison with in vitro liver metabolism | |||
| P478 | volume | 27 |
| Q64109830 | A Review of Cannabis in Chronic Kidney Disease Symptom Management |
| Q46420898 | A comparison between the metabolism of Δ1-tetrahydrocannabinol by perfused lung and liver of rat and guinea-pig |
| Q39253150 | Acidic metabolites of Δ1-tetrahydrocannabinol isolated from rabbit urine |
| Q57057796 | Biotransformation of Tetrahydrocannabinol |
| Q46373604 | Brain microsomal oxidation of delta 8- and delta 9-tetrahydrocannabinol |
| Q35940339 | Current knowledge on cannabinoids in oral fluid |
| Q39132149 | Dihydroxylated metabolites of cannabinol formed by rat liver in vitro |
| Q66702192 | Guide to urine testing in drug abuse prevention and multimodality treatment programs |
| Q90645483 | Hepatic Enzymes Relevant to the Disposition of (-)-∆9-Tetrahydrocannabinol (THC) and Its Psychoactive Metabolite, 11-OH-THC |
| Q24652736 | Human cannabinoid pharmacokinetics |
| Q39099175 | Identification of monohydroxylated metabolites of cannabidiol formed by rat liver |
| Q39161079 | In vivo metabolites of Δ1(6)-tetrahydrocannabinol produced by the mouse via the epoxide-diol pathway |
| Q72474988 | Induction studies of Δ1-tetrahydrocannabinol metabolism by rat and rabbit lungs |
| Q67769061 | Microbial transformation of (-)-delta1-3,4-trans-tetrahydro-cannabinol by Cunninghamella blakesleeana Lender |
| Q39253155 | More acidic metabolites of Δ1-tetrahydrocannabinol isolated from rabbit urine |
| Q34185013 | Pharmacokinetics and pharmacodynamics of cannabinoids |
| Q72387450 | Pharmacological potency of R- and S-3′-hydroxy-Δ9-tetrahydrocannabinol: additional structural requirement for cannabinoid activity |
| Q39404552 | The concept of regioselectivity in drug metabolism |
| Q40126230 | The isolated perfused lung — A critical evaluation |
| Q39699168 | delta7-Tetrahydrocannabinol, a non-psychotropic cannabinoid: structure-activity considerations in the cannabinoid series |
Search more.